BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3029148)

  • 1. Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Gudas LJ; Nodzenski E
    J Cell Physiol; 1987 Feb; 130(2):262-9. PubMed ID: 3029148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
    Albert DA; Nodzenski E; Yim G; Kowalski J
    J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase activity and deoxyribonucleoside triphosphate metabolism during the cell cycle of S49 wild-type and mutant mouse T-lymphoma cells.
    Albert DA; Gudas LJ
    J Biol Chem; 1985 Jan; 260(1):679-84. PubMed ID: 2981227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2 subunit of ribonucleotide reductase is a target of cyclic AMP-dependent protein kinase.
    Albert DA; Nodzenski E
    J Cell Physiol; 1989 Jan; 138(1):129-36. PubMed ID: 2536034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Nodzenski E
    Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
    Eriksson S; Skog S; Tribukait B; Wallström B
    Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
    Kucera R; Brown CL; Paulus H
    J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hydroxyurea (HYU) resistant S49 T lymphoma cells.
    Albert DA; Gudas LJ
    Adv Exp Med Biol; 1986; 195 Pt B():305-9. PubMed ID: 3020910
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.
    Albert DA
    J Clin Invest; 1995 Apr; 95(4):1490-6. PubMed ID: 7706453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ribonucleotide reductase activity in hydroxyurea-resistant mosquito cells.
    Gerenday A; Shih KM; Herman CC; Fallon AM
    Arch Insect Biochem Physiol; 2001; 46(1-2):19-25. PubMed ID: 11276057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
    Lewis WH; Wright JA
    J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of ribonucleotide reduction in nucleotide-permeable hamster cells.
    Lewis WH; Kuzik BA; Wright JA
    J Cell Physiol; 1978 Mar; 94(3):287-98. PubMed ID: 621224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory AH; Sato A; Thompson DP; Cory JG
    Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodeoxyuridine mutagenesis, ribonucleotide reductase activity, and deoxyribonucleotide pools in hydroxyurea-resistant mutants.
    Ashman CR; Reddy GP; Davidson RL
    Somatic Cell Genet; 1981 Nov; 7(6):751-68. PubMed ID: 7034251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase gene expression during cyclic AMP-induced cell cycle arrest in T lymphocytes.
    Albert DA; Nodzenski E
    Exp Cell Res; 1992 Dec; 203(2):476-82. PubMed ID: 1333983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of S49 lymphoma cell growth by cyclic adenosine 3':5'-monophosphate.
    Coffino P; Gray JW
    Cancer Res; 1978 Nov; 38(11 Pt 2):4285-8. PubMed ID: 212191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.